I-US Food and Drug Administration muva nje yenze intuthuko ebalulekile ekulweni nesifo i-Alzheimer's ngokwamukela i-donanemab, i-antibody ye-monoclonal eyakhiwe ngu-Eli Lilly. Njengoba ithengiswa ngaphansi kwegama elithi Kisunla, lokhu kwelashwa okusha kuhlose ukunciphisa ukuqhubekela phambili kwesifo i-Alzheimer's esinezimpawu zokuqala ngokusiza umzimba ukususa ukwakheka kwe-amyloid plaque ebuchosheni—okuwuphawu lwe-Alzheimer's. Lokhu kuvunywa akugcini nje ngokuphawula isikhathi esibalulekile ocwaningweni lwe-Alzheimer's kodwa futhi kugcizelela ukubaluleka kokutholakala nokungenelela kusenesikhathi.
I-Kisunla: Isahluko Esisha Ekwelashweni Kwe-Alzheimer's
I-Donanemab, noma i-Kisunla, ayilona ikhambi le-Alzheimer's kodwa ibonise imiphumela ethembisayo ezivivinyweni zemitholampilo. Abahlanganyeli abathathe i-Kisunla babhekane nengozi ephansi ngo-35% yokuqhubeka kwesifo ezinyangeni ezingu-18 uma kuqhathaniswa nalabo abasebenzisa i-placebo. Lokhu kusho ukuthi iziguli zingaphila ngokuzimela kakhudlwana futhi zihlanganyele ngokuphephile emisebenzini yansuku zonke isikhathi eside.
Kodwa-ke, kubalulekile ukuqaphela ukuthi ukwelashwa akunazo izingozi. Cishe u-2% wabahlanganyeli babhekane nezehlakalo ezimbi kakhulu, okuhlanganisa nokukhubazeka kwezithombe okuhlobene ne-amyloid (ARIA), okungaholela ekuphumeni kwegazi okuncane ebuchosheni. Naphezu kwalezi zingozi, abeluleki be-FDA bakubone ukwelashwa kuphephile futhi kusebenza kahle, uma kubhekwa izinzuzo zako ezingaba khona.
Ukubaluleka Kokutholwa Kwasekuqaleni
Ukutholwa kusenesikhathi kanye nokuxilongwa kubalulekile ekwelapheni okuphumelelayo kwesifo i-Alzheimer's. I-Kisunla isebenza kahle kakhulu ezigabeni zokuqala zezimpawu, okwenza u-Eli Lilly abambisane nezinye izinhlangano ukuthuthukisa izindlela zokutholwa kusenesikhathi. Lesi sinyathelo sihambisana nesidingo esikhulayo sokungenelela kusenesikhathi, ikakhulukazi njengoba inani lamacala e-Alzheimer's kulindeleke ukuthi lifinyelele cishe ezigidini ezingu-14 ngo-2060.
Indima Yokunakekelwa Kwasekhaya Ekuphathweni Kwe-Alzheimer's
Njengoba isifo i-Alzheimer's siqhubeka, indima yabanakekeli iba yinto ebaluleke kakhulu. Abanakekeli abanakekelayo abanakekelayo, abahlinzeka ngokunakekelwa okuqhubekayo nokusekelwa, badlala indima ebalulekile ekuqinisekiseni ukuphepha nenhlalakahle yeziguli ze-Alzheimer's. Emindenini ephatha i-Alzheimer's ekhaya, imikhiqizo efana naleyo enikezwa yi-LIREN Healthcare ingaba usizo olukhulu.
I-LIREN Healthcare igxile emikhiqizweni yokunakekelwa kwempilo yabantu abadala eyenzelwe ukuthuthukisa ukuphepha kwasekhaya kanye nokusebenza kahle kokunakekelwa. Uhla lwethu luhlanganisa ukucindezeleka kombhede nesihlalo.ama-sensor pad, ukuxwayisaama-pager, futhiizinkinobho zokushaya ucingo, konke okubalulekile ekudaleni indawo yokuhlala ephephile nephephile yabantu abadala.
Ukuthuthukisa Ukuphepha Kwasekhaya Ngemikhiqizo Yezempilo ye-LIREN
1. Ama-Pressure Sensor Pads: Lawa ma-pads abekwa emibhedeni noma ezihlalweni ukuze kuqashwe ukunyakaza futhi kutholakale ukuthi umuntu osekhulile uvuka nini, ngaleyo ndlela kuvinjelwe ukuwa.
2. Ama-Pager Axwayisayo: Lawa madivayisi azisa abanakekeli ngokushesha lapho umuntu osekhulile edinga usizo, okuqinisekisa impendulo esheshayo futhi kunciphisa ingozi yezingozi.
3. Izinkinobho Zokufona: Lokhu kuvumela abantu abadala ukuthi bacele usizo ngokucindezela okulula, okunikeza ukuthula kwengqondo kokubili iziguli kanye nabanakekeli bazo.
Ngokuhlanganisa imikhiqizo ye-LIREN Healthcare ekusethweni kokunakekelwa kwasekhaya, imindeni ingadala indawo ephephile yabathandekayo bayo. Kulabo abacabanga ukufaka uhlelo lwe-alamu yokuphepha, ukufaka ama-pressure sensor pads kanye nama-alert pager kungaba yinto ebalulekile enqubweni yokubuka ukunakekelwa kwasekhaya.
Ukuvikeleka Nokuthula Kwengqondo
Ukufaka uhlelo lokuphepha oluhlanganisa imikhiqizo ye-LIREN Healthcare kungathuthukisa kakhulu ukuphepha nokuvikeleka kwesiguli esine-Alzheimer's ekhaya. Inqubo yethu yokufaka uhlelo lwe-alamu yokuphepha ilula futhi yenzelwe ukuhlinzeka ngokuvikelwa okuphezulu ngokuphazamiseka okuncane.
Ukubheka Phambili
Ukuvunyelwa kweKisunla kubonisa intuthuko enkulu ekwelashweni kwe-Alzheimer's, okunikeza ithemba elisha ezigidini ezithintekile yilesi sifo esibhubhisayo. Njengoba siqhubeka nokuhlola nokuthuthukisa izindlela zokwelapha ezintsha, indima yokunakekelwa kwasekhaya kanye nemikhiqizo emisha efana naleyo evela ku-LIREN Healthcare izoba yinto ebaluleke kakhulu ekuphatheni isifo se-Alzheimer's.
Ukuze uthole ulwazi olwengeziwe mayelana nendlela imikhiqizo ye-LIREN Healthcare engakusiza ngayo ukudala indawo ephephile yasekhaya yabathandekayo bakho, vakashela iwebhusayithi yethu. Hlala unolwazi ngentuthuko yakamuva kwezempilo yabadala futhi uthole izixazululo ezinhle kakhulu zokuthuthukisa ikhwalithi yokuphila kwabadala.
Isifinyezo
Impi yokulwa nesifo i-Alzheimer's isekude ukuphela, kodwa ngentuthuko efana neKisunla kanye nokusekelwa okuqhubekayo kwemikhiqizo yokunakekelwa kwasekhaya evela ezinkampanini ezifana neLIREN Healthcare, kunethemba lekusasa elingcono. Njengoba samukela lezi ntuthuko ezintsha, ukuqinisekisa ukuphepha kanye nenhlalakahle yeziguli ze-Alzheimer's kusalokhu kuyinto eza kuqala kithi.
Vakashela iwebhusayithi ye-LIREN Healthcare namuhla ukuze ufunde kabanzi ngemikhiqizo yethu nokuthi ingakusiza kanjani ukuthi wakhe indawo ephephile nephephile yasekhaya yabathandekayo bakho. Hlala uxhumene nathi ukuze uthole izindaba zakamuva kanye nezibuyekezo mayelana nokunakekelwa kwempilo kwabantu abadala.
Umthombo wezindaba:https://edition.cnn.com/2024/07/02/health/lilly-azheimers-donanemab-fda/index.html
I-LIREN ifuna ngenkuthalo abasabalalisi abazobambisana nabo ezimakethe ezibalulekile. Abantu abanentshisekelo bayakhuthazwa ukuthi baxhumane nabo nge-customerservice@lirenltd.comukuthola imininingwane eyengeziwe.
Isikhathi sokuthunyelwe: Julayi-08-2024
